Jaffray Initiates Coverage on Insmed Our top large-cap picks are GILD, AMGN and ALXN. Our top small/mid cap picks are GWPH, NKTR, CMRX, INSM, VNDA and RPRX.”
Sentiment: Strong Buy
Did I miss the headline of that? I know about it from last night but haven't seen it today. Where did you see the above?
I have TD Ameritrade its in there news.
0:48a ET November 27, 2013 (Benzinga)
In a report published Wednesday, Piper Jaffray analyst Joshua E. Schimmer initiated coverage on Insmed (NASDAQ: INSM) with an Overweight rating and $34.00 price target.